Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
Titel:
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
Auteur:
Mega, JL Braunwald, E Mohanavelu, S Burton, P Poulter, R Misselwitz, F Hricak, V Barnathan, ES Bordes, P Witkowski, A Markov, V Oppenheimer, L Gibson, CM